allantoin has been researched along with Dermatitis, Seborrheic in 1 studies
Dermatitis, Seborrheic: A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veraldi, S | 1 |
| Menter, A | 1 |
| Innocenti, M | 1 |
1 trial available for allantoin and Dermatitis, Seborrheic
| Article | Year |
|---|---|
Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial.
Topics: Administration, Topical; Adult; Aged; Alkanes; Allantoin; Dermatitis, Seborrheic; Dermatologic Agent | 2008 |